Understanding the role of mitochondrial UPR-activating mtDNA landscapes in health and longevity.
了解线粒体 UPR 激活 mtDNA 景观在健康和长寿中的作用。
基本信息
- 批准号:10172817
- 负责人:
- 金额:$ 36.13万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2018
- 资助国家:美国
- 起止时间:2018-08-01 至 2023-04-30
- 项目状态:已结题
- 来源:
- 关键词:AffectAgingAntioxidantsBindingBiologicalCaloric RestrictionClustered Regularly Interspaced Short Palindromic RepeatsComplexCongenic MiceDNA SequenceDiseaseDisease ProgressionEstrogen Receptor alphaEstrogensExerciseFamilyFemaleGenesGeneticGenetic TranscriptionGenomeGenomicsHealthHealth BenefitHeartInterventionLeadLinkLiverLongevityMitochondriaMitochondrial DNAMitochondrial ProteinsModelingMusMutationNuclearPPAR alphaPeptide HydrolasesPeroxisome Proliferator-Activated ReceptorsProteinsReactive Oxygen SpeciesReportingRoleSOD2 geneStressTestingTissuescombinatorialestrogen-related receptorgender differencegenome-widehealth differenceimprovedloss of functionmalemouse modelproteotoxicityresponsesmall hairpin RNAtranscription factor
项目摘要
The results of a recent study suggest an intriguing link between mitochondrial genetics and health. This study
used C57BL-nuclear-genome matched conplastic mice, where one strain carries mitochondria from the C57BL
background (BL6C57) and the other strain carries the mitochondria from the NZ background (BL6NZB). The
authors reported that mice carrying NZB mitochondrial DNA (mtDNA) are healthier and show significant
differences in longevity despite sharing the same nuclear genome as the BL6C57 mice. Since the mtDNA of
NZB and C57BL6 mice vary by only a few mutations, their findings suggest that small changes in mitochondirla
genetics can cause large difference in health and longevity. They reported that these differences correlated
with a number of changes that are consistent with the activation of axes of the mitochondrial unfolded protein
response (UPRmt) identified in the Germain's lab. One axis is regulated by SIRT3 and FOXO3a, both key
regulators of aging. Another axis is regulated by the estrogen receptor alpha (ERα). We also recently reported
that small differences in mtDNA sequence can lead to differential activation of the axes of the UPRmt and also
that their activation varies between males and females. Our central hypothesis is that the differences between
the conplastic mice are due to the ability mtDNA of the BL6NZB to activate the UPRmt and will differ not only
between males and females. To test this hypothesis, we propose the following three aims:
Specific aim 1: Assess the activation of the UPRmt in tissues in the BL6C57 males and females versus BL6NZB
males and females congenic mice.
Specific aim 2: Test whether deleting key genes of each UPRmt nodes abolishes the health benefit of the
BL6NZB conplastic mice.
Specific aim 3: Assess whether interventions known to increase SIRT3, FOXO3a or ERα improve the health
and longevity of BL6C57 conplastic mice.
最近的一项研究结果表明,线粒体遗传学与健康之间存在有趣的联系。本研究
使用C57 BL-核基因组匹配的共质体小鼠,其中一个品系携带来自C57 BL的线粒体
另一个菌株携带来自NZ背景的线粒体(BL 6C 57),另一个菌株携带来自NZ背景的线粒体(BL 6 NZB)。的
作者报告说,携带NZB线粒体DNA(mtDNA)的小鼠更健康,
尽管与BL 6C 57小鼠共享相同的核基因组,但它们的寿命存在差异。由于线粒体DNA的
NZB和C57 BL 6小鼠只有几个突变不同,他们的发现表明线粒体的微小变化
基因会导致健康和寿命的巨大差异。他们报告说,这些差异与
与线粒体未折叠蛋白轴的激活一致的许多变化
反应(UPRmt)在Germain的实验室确定。一个轴由SIRT 3和FOXO 3a调节,这两个轴都是关键。
老化的调节器。另一个轴由雌激素受体α(ERα)调节。我们最近还报道
线粒体DNA序列的微小差异可以导致UPRmt轴的差异激活,
它们的激活在男性和女性之间是不同的。我们的核心假设是,
共质体小鼠是由于BL 6 NZB的mtDNA激活UPRmt的能力,
男性和女性之间。为了验证这一假设,我们提出了以下三个目标:
具体目的1:评估BL 6C 57雄性和雌性动物与BL 6 NZB的组织中UPRmt的活化
雄性和雌性同类小鼠。
具体目标2:测试删除每个UPRmt节点的关键基因是否会消除UPRmt节点的健康益处。
BL 6 NZB共体小鼠。
具体目标3:评估已知增加SIRT 3、FOXO 3a或ERα的干预措施是否改善健康
和BL 6C 57同源小鼠的寿命。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
DORIS A GERMAIN其他文献
DORIS A GERMAIN的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('DORIS A GERMAIN', 18)}}的其他基金
Exploring ovarian-derived hormone STC1 as the mediator of the protective effect of breast feeding against breast cancer.
探索卵巢源性激素 STC1 作为母乳喂养对乳腺癌保护作用的中介。
- 批准号:
10563256 - 财政年份:2023
- 资助金额:
$ 36.13万 - 项目类别:
Understanding the influence of Mitochondrial DNA haplotypes on breast aging and cancer
了解线粒体 DNA 单倍型对乳腺癌衰老和癌症的影响
- 批准号:
10591676 - 财政年份:2023
- 资助金额:
$ 36.13万 - 项目类别:
Raloxifene-based therapy in neuro degenerative diseases
基于雷洛昔芬的神经退行性疾病治疗
- 批准号:
10532927 - 财政年份:2020
- 资助金额:
$ 36.13万 - 项目类别:
Raloxifene-based therapy in neuro degenerative diseases
基于雷洛昔芬的神经退行性疾病治疗
- 批准号:
10307584 - 财政年份:2020
- 资助金额:
$ 36.13万 - 项目类别:
Raloxifene-Based Therapy in Neuro Degenerative Diseases
基于雷洛昔芬的神经退行性疾病治疗
- 批准号:
10535475 - 财政年份:2020
- 资助金额:
$ 36.13万 - 项目类别:
The role of the mitochondrial unfolded protein response (UPRmt) in the etiology of breast cancer in young versus elderly women.
线粒体未折叠蛋白反应 (UPRmt) 在年轻与老年女性乳腺癌病因学中的作用。
- 批准号:
9927550 - 财政年份:2019
- 资助金额:
$ 36.13万 - 项目类别:
Exploring the use of conplastic mice as a model of risk stratification of coronavirus susceptibility
探索使用再生小鼠作为冠状病毒易感性风险分层模型
- 批准号:
10162776 - 财政年份:2018
- 资助金额:
$ 36.13万 - 项目类别:
Understanding the role of mitochondrial UPR-activating mtDNA landscapes in health and longevity.
了解线粒体 UPR 激活 mtDNA 景观在健康和长寿中的作用。
- 批准号:
9923529 - 财政年份:2018
- 资助金额:
$ 36.13万 - 项目类别:
Understanding the role of mitochondrial UPR-activating mtDNA landscapes in health and longevity.
了解线粒体 UPR 激活 mtDNA 景观在健康和长寿中的作用。
- 批准号:
10417179 - 财政年份:2018
- 资助金额:
$ 36.13万 - 项目类别:
Understanding the role of mitochondrial UPR-activating mtDNA landscapes in health and longevity.
了解线粒体 UPR 激活 mtDNA 景观在健康和长寿中的作用。
- 批准号:
9752438 - 财政年份:2018
- 资助金额:
$ 36.13万 - 项目类别:
相似海外基金
Potential of Oxyresveratrol and other antioxidants to protect cells from trauma and aging
氧化白藜芦醇和其他抗氧化剂具有保护细胞免受创伤和衰老的潜力
- 批准号:
415301-2011 - 财政年份:2011
- 资助金额:
$ 36.13万 - 项目类别:
University Undergraduate Student Research Awards
Anti-aging effects of novel antioxidants Design, synthesis and testing for chemical and biological activity.
新型抗氧化剂的抗衰老作用化学和生物活性的设计、合成和测试。
- 批准号:
234723-2000 - 财政年份:2002
- 资助金额:
$ 36.13万 - 项目类别:
Strategic Projects - Group
Anti-aging effects of novel antioxidants Design, synthesis and testing for chemical and biological activity.
新型抗氧化剂的抗衰老作用化学和生物活性的设计、合成和测试。
- 批准号:
234723-2000 - 财政年份:2001
- 资助金额:
$ 36.13万 - 项目类别:
Strategic Projects - Group
ANTIOXIDANTS AND REPERFUSION INJURY IN AGING HEART
衰老心脏中的抗氧化剂和再灌注损伤
- 批准号:
6359552 - 财政年份:2000
- 资助金额:
$ 36.13万 - 项目类别:
Anti-aging effects of novel antioxidants Design, synthesis and testing for chemical and biological activity.
新型抗氧化剂的抗衰老作用化学和生物活性的设计、合成和测试。
- 批准号:
234723-2000 - 财政年份:2000
- 资助金额:
$ 36.13万 - 项目类别:
Strategic Projects - Group
ANTIOXIDANTS AND REPERFUSION INJURY IN AGING HEART
衰老心脏中的抗氧化剂和再灌注损伤
- 批准号:
6218772 - 财政年份:1999
- 资助金额:
$ 36.13万 - 项目类别:
ANTIOXIDANTS AND REPERFUSION INJURY IN AGING HEART
衰老心脏中的抗氧化剂和再灌注损伤
- 批准号:
6098816 - 财政年份:1999
- 资助金额:
$ 36.13万 - 项目类别:
ANTIOXIDANTS AND REPERFUSION INJURY IN AGING HEART
衰老心脏中的抗氧化剂和再灌注损伤
- 批准号:
6267774 - 财政年份:1998
- 资助金额:
$ 36.13万 - 项目类别:
Mitochondrial Antioxidants, Aging and Healthspan
线粒体抗氧化剂、衰老和健康寿命
- 批准号:
8431784 - 财政年份:1997
- 资助金额:
$ 36.13万 - 项目类别:
Mitochondrial Antioxidants, Aging and Healthspan
线粒体抗氧化剂、衰老和健康寿命
- 批准号:
8816010 - 财政年份:1997
- 资助金额:
$ 36.13万 - 项目类别: